We are proud to share that our COO, Rebecca Stjernberg Bejhed, recently visited one of our partnering hospitals to oversee the progress of clinical trials for our innovative ReLink catheter protection device. These trials mark a significant step forward in our ongoing mission to enhance patient safety, with a specific focus on animal healthcare.
By leveraging a combination of expertise and resources, our collaboration with leading EU institutions is driving new possibilities in veterinary medicine. Through these partnerships, we are continuously advancing medical solutions designed to improve both safety and efficiency. This cross-border collaboration underscores the importance of teamwork in developing cutting-edge medical devices that have the potential to revolutionize healthcare globally.
As we continue to push boundaries, we remain committed to delivering impactful solutions that not only improve patient outcomes but also set new standards in animal healthcare across the globe.
Stay tuned for more updates as the clinical trials progress!
About ReLink:ReLink is a breakthrough IV catheter protection device that enhances patient safety in various medical fields, from human to veterinary care, preventing catheter dislodgement and reducing the risk of complications.
Comments